Modulation of CD4 T cell function via CD6-targetingResearch in context

In recent years molecules involved on the immune synapse became successful targets for therapeutic immune modulation. CD6 has been extensively studied, yet, results regarding CD6 biology have been controversial, in spite of the ubiquitous presence of this molecule on virtually all CD4 T cells. We in...

Full description

Saved in:
Bibliographic Details
Published in:EBioMedicine 2019-09, Vol.47, p.427-435
Main Authors: Raquel Filipa Freitas, Afonso Basto, Silvia C.P. Almeida, Rita F. Santos, Carine M. Gonçalves, Jesus Corria-Osorio, Tânia Carvalho, Alexandre M. Carmo, Vanessa G. Oliveira, Kalet Leon, Luis Graca
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In recent years molecules involved on the immune synapse became successful targets for therapeutic immune modulation. CD6 has been extensively studied, yet, results regarding CD6 biology have been controversial, in spite of the ubiquitous presence of this molecule on virtually all CD4 T cells. We investigated the outcome of murine and human antibodies targeting CD6 domain 1. We found that CD6-targeting had a major impact on the functional specialization of CD4 cells, both human and murine. Differentiation of CD4 T cells towards a Foxp3+ Treg fate was prevented with increasing doses of anti-CD6, while Th1 polarization was favoured. No impact was observed on Th2 or Th17 specialization. These in vitro results provided an explanation for the dose-dependent outcome of in vivo anti-CD6 administration where the anti-inflammatory action is lost at the highest doses. Our data show that therapeutic targeting of the immune synapse may lead to paradoxical dose-dependent effects due to modification of T cell fate. Keywords: CD6, CD4 T cells, Treg cells, Foxp3, EAE, T-cell polarization
ISSN:2352-3964
2352-3964